US55261F1049 - Common Stock - After market: 114.93 0 (0%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-03-24 | RBC Capital | Maintains | Outperform |
2023-03-23 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
2023-02-22 | Citigroup | Maintains | Neutral |
2023-01-23 | JP Morgan | Maintains | Neutral |
2023-01-23 | Morgan Stanley | Maintains | Overweight |
2023-01-10 | Odeon Capital | Upgrade | Hold -> Buy |
2023-01-03 | Barclays | Downgrade | Overweight -> Equal-Weight |
2023-01-03 | Wedbush | Upgrade | Neutral -> Outperform |
2022-12-21 | DA Davidson | Initiate | Neutral |
2022-12-16 | Morgan Stanley | Maintains | Overweight |
2022-12-13 | JP Morgan | Maintains | Neutral |
2022-12-08 | Wells Fargo | Maintains | Equal-Weight |
2022-12-07 | Keefe, Bruyette & Woods | Downgrade | Outperform -> Market Perform |
2022-12-05 | Morgan Stanley | Maintains | Overweight |
2022-10-21 | Citigroup | Maintains | Neutral |
2022-10-20 | Barclays | Maintains | Overweight |
2022-10-20 | Wedbush | Maintains | Neutral |
2022-10-20 | Morgan Stanley | Maintains | Overweight |
2022-10-20 | Piper Sandler | Maintains | Overweight |
2022-10-05 | Morgan Stanley | Maintains | Overweight |
2022-10-04 | Citigroup | Downgrade | Buy -> Neutral |
2022-09-12 | Deutsche Bank | Maintains | Buy |
2022-07-21 | Barclays | Maintains | Overweight |
2022-07-21 | Morgan Stanley | Maintains | Overweight |
2022-07-12 | Morgan Stanley | Maintains | Overweight |
2022-07-11 | Jefferies | Maintains | Hold |
2022-07-01 | Wells Fargo | Maintains | Equal-Weight |
2022-07-01 | JP Morgan | Maintains | Neutral |
2022-06-17 | Baird | Upgrade | Neutral -> Outperform |
2022-05-26 | Wolfe Research | Maintains | Outperform |
Find the competitors with the best analyst ratings on the USA